Health · 53 views
Early cranial radiotherapy may improve outcomes for patients with EGFR-mutant NSCLC and limited brain metastases
Early cranial stereotactic radiotherapy (SRT) administered with first-line osimertinib was associated with improved intracranial control and survival outcomes in patients with EGFR-mutant non-small cell lung cancer (NSCLC) and limited…
Summary
Early cranial stereotactic radiotherapy (SRT) administered with first-line osimertinib was associated with improved intracranial control and survival outcomes in patients with EGFR-mutant non-small cell lung cancer (NSCLC) and limited brain metastases, according to research presented at the International Association for the Study of Lung Cancer (IASLC) 2026
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedCoverage Context
More from Health
Continue reading recent Health coverage
- Reducing hallucinations in schizophrenia with focused ultrasound: First-in-human clinical trial beginsContinue reading
- CTE in NFL Players: What a New Study Tells Us -- And What It Doesn'tContinue reading
- Parents' Autoimmune Disease Linked to Kids' Type 1 Diabetes RiskContinue reading
- How an innate immune protein can control cholesterol, tumor growth and response to cancer therapyContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow